☆ 4.1 Article

Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us

METABOLIC SYNDROME AND RELATED DISORDERS (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes

Pantea Stoian Anca et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Immunology

Empagliflozin suppresses inflammation and protects against acute septic renal injury

Zaid H. Maayah et al.

Summary: The study suggests that empagliflozin has a positive impact on acute sepsis-induced renal injury, improving survival and reducing inflammation. By reducing systemic and renal inflammation, empagliflozin has the potential to decrease mortality rates in patients with acute septic renal injury.

INFLAMMOPHARMACOLOGY (2021)

Add to Collection

Article Nutrition & Dietetics

High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients

Estefania Alcantara-Alonso et al.

Summary: The Tg/HDLc ratio can serve as an early biochemical marker for severe prognosis of COVID-19, particularly in predicting the need for invasive mechanical ventilation. It showed significant correlations with disease severity and other indicators in the study, providing valuable insights into predicting the requirement for mechanical ventilation in patients.

CLINICAL NUTRITION ESPEN (2021)

Add to Collection

Editorial Material Endocrinology & Metabolism

Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action

Michael A. Hill et al.

Summary: Obesity and cardiometabolic disorders play a major role in poor outcomes of COVID-19 infections, forming a 'syndemic' that requires ongoing attention. A multidisciplinary approach is needed to manage obesity patients, reduce the burden of cardiovascular complications, and mitigate the impact of future viral pandemics.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Add to Collection

Article Cell Biology

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

Bo Yu et al.

Summary: Insulin treatment for patients with COVID-19 and T2D was found to be associated with a significant increase in mortality according to a retrospective study. Further analysis showed that insulin treatment was linked to enhanced systemic inflammation and aggravated injuries of vital organs, suggesting that caution should be exercised when using insulin treatment for these patients.

CELL METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission

Harald Sourij et al.

Summary: This study aimed to assess predictors of in-hospital mortality in people with prediabetes and diabetes hospitalized for COVID-19 infection, finding that the in-hospital mortality rate was higher in people with diabetes compared to those with prediabetes but without statistical significance. A risk score using five routinely available patient variables, including age, arterial occlusive disease, C-reactive protein, estimated glomerular filtration rate, and aspartate aminotransferase levels, showed excellent predictive performance for assessing in-hospital mortality.

DIABETES OBESITY & METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19

Jihoon Shin et al.

Summary: This study found that the SARS-CoV-2 spike protein interacts with cell surface GRP78, promoting binding and accumulation in ACE2-expressing cells. High expression of GRP78 in adipose tissue is associated with older age, obesity, and diabetes. Pharmacological and environmental interventions that target hyperinsulinemia can decrease GRP78 expression in adipose tissue, potentially providing a therapeutic or preventative target for severe COVID-19 cases in patients with underlying risk factors.

DIABETES (2021)

Add to Collection

Article Biochemical Research Methods

NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines

Samantha Lodge et al.

Summary: The study investigated the systemic metabolic effects of SARS-CoV-2 infection by analyzing H-1 NMR spectroscopic data on human blood plasma. The findings revealed that some patients in the respiratory recovery phase, with no detectable virus, still exhibited highly abnormal metabolism, indicating a new role for these technologies in assessing full systemic recovery.

JOURNAL OF PROTEOME RESEARCH (2021)

Add to Collection

Article Endocrinology & Metabolism

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

Andrew B. Crouse et al.

Summary: The study found that Black/African-Americans, obesity, hypertension, and diabetes were associated with higher likelihood of contracting COVID-19. Diabetes was also linked to a dramatic increase in COVID-19-related mortality, but the use of metformin showed a significant reduction in mortality for diabetic individuals with COVID-19.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

COVID-19 and metabolic disease: mechanisms and clinical management

Charlotte Steenblock et al.

Summary: Up to 50% of COVID-19 fatalities are associated with metabolic and vascular disorders. COVID-19 has direct links with the metabolic and endocrine systems, increasing the risk and severity of the disease in patients with metabolic dysfunction such as obesity, hypertension, non-alcoholic fatty liver disease, and diabetes.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review

Djordje S. Popovic et al.

Summary: SARS-CoV-2 causes COVID-19, which can lead to severe illness and complications, especially for patients with T2DM. Urgent research is needed on antidiabetic agents to improve outcomes for these patients in relation to COVID-19.

DIABETES THERAPY (2021)

Add to Collection

Article Multidisciplinary Sciences

Low HDL and high triglycerides predict COVID-19 severity

Lluis Masana et al.

Summary: The presence of atherogenic dyslipidaemia during COVID-19 infection is strongly associated with a worse prognosis. Low HDL cholesterol and high triglyceride concentrations, either before or during hospitalization, are strong predictors of a severe course of the disease. Lipid profiles can be considered as sensitive markers of inflammation in patients with COVID-19 and should be measured.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Endocrinology & Metabolism

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

Mikhail N. Kosiborod et al.

Summary: The DARE-19 trial showed that treatment with dapagliflozin in patients hospitalized with COVID-19 and cardiometabolic risk factors did not significantly reduce the risk of organ dysfunction or death, or improve clinical recovery, but was well tolerated.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19

Rami A. Ballout et al.

Summary: There is a complex relationship between plasma lipoproteins and inflammation, especially in the context of diseases like atherosclerosis and respiratory viral infections. Severe COVID-19 patients exhibit altered plasma lipoprotein levels, including reduced HDL particles and increased triglyceride-rich lipoprotein particles, along with elevated levels of GlycA, branched-chain amino acids, and beta-hydroxybutyrate. Additionally, elevated levels of lipoproteins X and Z, markers of hepatic dysfunction, were detected in most participants, indicating a potential novel finding in this study.

BIOMEDICINES (2021)

Add to Collection

Article Endocrinology & Metabolism

Finding answers in lipid profile in COVID-19 patients

M. Sampedro-Nunez et al.

Summary: This study evaluated the association between lipid abnormalities and prognosis in COVID-19 patients, finding that decreased levels of T-c, HDL-c, and LDL-c were associated with lower albumin levels. The study also found that patients with lower levels of T-c, HDL-c, and LDL-c were more likely to be admitted to the ICU, while higher levels of these lipids were associated with a protective effect on mortality.

ENDOCRINE (2021)

Add to Collection

Review Endocrinology & Metabolism

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Soo Lim et al.

Summary: Initial studies have shown that patients with diabetes mellitus have a higher risk of severe COVID-19, potentially due to hyperglycaemia affecting immune and inflammatory responses. Further investigation is needed to determine the optimal management for patients with diabetes mellitus during the ongoing pandemic.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients withCOVID-19

Huiqing Li et al.

DIABETES OBESITY & METABOLISM (2020)

Add to Collection

Editorial Material Endocrinology & Metabolism

COVID-19 and diabetes: Can DPP4 inhibition play a role?

Gianluca Iacobellis

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Editorial Material Endocrinology & Metabolism

COVID-19 and diabetes management: What should be considered?

Antonio Ceriello et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Article Endocrinology & Metabolism

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand Cariou et al.

DIABETOLOGIA (2020)

Add to Collection

Review Infectious Diseases

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Jing Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Infectious Diseases

COVID-19 spike-host cell receptor GRP78 binding site prediction

Ibrahim M. Ibrahim et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Medicine, Research & Experimental

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management

Anca Pantea Stoian et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2020)

Add to Collection

Review Endocrinology & Metabolism

Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?

Paul MacDaragh Ryan et al.

OBESITY (2020)

Add to Collection

Article Endocrinology & Metabolism

Diabetes and COVID-19: IDF perspective in the Western Pacific region

Yerin Hwang et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Letter Medicine, General & Internal

Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy

Manfredi Rizzo et al.

JAMA INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Giacomo Grasselli et al.

JAMA INTERNAL MEDICINE (2020)

Add to Collection

Article Endocrinology & Metabolism

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Naomi Holman et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Commentary: COVID-19 in patients with diabetes

Michael A. Hill et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Add to Collection

Article Endocrinology & Metabolism

Severe obesity, increasing age and male sex are independently associated with worse in -hospital outcomes, and higher in -hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

Leonidas Palaiodimos et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Add to Collection

Article Cell Biology

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

Xu Cheng et al.

CELL METABOLISM (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Covid-19 and Disparities in Nutrition and Obesity

Matthew J. Belanger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Endocrinology & Metabolism

COVID-19 in people living with diabetes: An international consensus

A. E. Caballero et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)

Add to Collection

Letter Infectious Diseases

The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection

Dat P. Ha et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Multidisciplinary Sciences

Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study

Anca Pantea Stoian et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Endocrinology & Metabolism

Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis

Samit Ghosal et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Add to Collection

Article Endocrinology & Metabolism

Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis

Erkan Cure et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

Salvatore De Rosa et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Medicine, Research & Experimental

Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic

Kewen Qian et al.

MABS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

Salvatore De Rosa et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Biochemistry & Molecular Biology

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

Manfredi Rizzo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Add to Collection

Review Endocrinology & Metabolism

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease

F. Bonnet et al.

DIABETES & METABOLISM (2018)

Add to Collection

Article Endocrinology & Metabolism

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Giuseppe Daniele et al.

DIABETES CARE (2016)

Add to Collection

Article Pharmacology & Pharmacy

Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome

Nicola Abate et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Add to Collection

Article Pharmacology & Pharmacy

Prevalence of dyslipidemia and associated risk factors in Turkish adults

Fahri Bayram et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2014)

Add to Collection

Article Endocrinology & Metabolism

Ethnic differences in serum lipoproteins and their determinants in South African women

Julia H. Goedecke et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2010)

Add to Collection

Review Medicine, General & Internal

Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts

Ali A. Rizvi

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis

Manfredi Rizzo et al.

ATHEROSCLEROSIS (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

Manfredi Rizzo et al.

ATHEROSCLEROSIS (2008)

Add to Collection

Review Pharmacology & Pharmacy

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes

Kaspar Berneis et al.

EXPERT OPINION ON PHARMACOTHERAPY (2008)

Add to Collection

Review Medicine, General & Internal

Who needs to care about small, dense low-density lipoproteins?

M. Rizzo et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)

Add to Collection

Article Biochemical Research Methods

The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress

AS Lee

METHODS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.